| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Jul 17, 2025 | Jul 18, 2025 | Disc Medicine, Inc. | CFO | Sell | 37.5 | -2,031 | -3.10% | ✓ | $119.8K |
| Jul 10, 2025 | Jul 14, 2025 | Disc Medicine, Inc. | CFO | Sell | 41.3 | -2,000 | -2.96% | ✓ | $115K |
| Jun 16, 2025 | Jun 18, 2025 | Disc Medicine, Inc. | CFO | Sell | 41.3 | -2,000 | -2.88% | ✓ | $104.5K |
| Feb 18, 2025 | Feb 20, 2025 | Disc Medicine, Inc. | CFO | Sell | 42.5 | -3,136 | -4.32% | ✗ | $171.2K |
| May 16, 2023 | May 18, 2023 | Replimune Group, Inc. | CFO | Sell | 42.5 | -11,351 | -8.10% | ✗ | $204.9K |
| May 16, 2022 | May 18, 2022 | Replimune Group, Inc. | CFO | Sell | 42.5 | -3,436 | -3.49% | ✗ | $50.1K |
| Jan 13, 2021 | Jan 15, 2021 | Replimune Group, Inc. | CFO | Sell | 7.5 | -15,000 | -96.15% | ✓ | $667.9K |
| Dec 14, 2020 | Dec 16, 2020 | Replimune Group, Inc. | CFO | Sell | 5.0 | -25,000 | -100.00% | ✓ | $1.1M |